Buscar
Mostrando ítems 1-10 de 565
Strategies of the Brazilian Chronic Kidney Disease Prevention Campaign (2003-2009)
(Karger, 2011-01-01)
In Brazil, as in the rest of the world, the prevalence of chronic kidney disease (CKD) is increasing. in order to alert the population, health professionals and authorities to this risk, in 2003, the Brazilian Society of ...
Frequency and clinical profile of patients with polycystic kidney disease in Southern Brazil
(TAYLOR & FRANCIS INC, 2008)
Background. Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic nephropathies, affecting one in every 800-1000 individuals in the worldwide general population and 5-10% of hemodialysis ...
Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?
(MDPI, 2023)
SGLT-2i are the new standard of care for diabetic kidney disease (DKD), but previous studies have not included patients on kidney replacement therapy (KRT). Due to their high risk of cardiovascular, renal complications, ...
Management of hepatitis C in patients with chronic kidney disease
(Baishideng Publishing Group Inc, 2015-01-14)
Hepatitis C virus (HCV) infection is highly prevalent among chronic kidney disease (CKD) subjects under hemodialysis and in kidney transplantation (KT) recipients, being an important cause of morbidity and mortality in ...
Assessment of physical activity by accelerometer and IPAQ-short version in patients with chronic kidney disease undergoing hemodialysis
(S. Karger AG, Basel, 2015-09-26)
To compare the short version of International Physical Activity Questionnaire (IPAQ) and the accelerometer measurement of physical activity (PA) in patients undergoing hemodialysis. Sample consisted of 40 patients (19 men) ...
Recognition of visceral obesity beyond body fat: assessment of cardiovascular risk in chronic kidney disease using anthropometry
(2017-12-01)
Evaluation of body fat and its distribution are important because they can predict several risk factors, mainly cardiovascular risk. Imaging techniques have high precision and accuracy for body fat measurement. However, ...
The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy
(2004-09-15)
Renal interstitial fibrosis has been observed in a large number of nephropathies and contributes to the progressive deterioration of renal function. Myofibroblasts have been implicated in the reparative process of tissue ...
The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy
(2004-09-15)
Renal interstitial fibrosis has been observed in a large number of nephropathies and contributes to the progressive deterioration of renal function. Myofibroblasts have been implicated in the reparative process of tissue ...
Hepatitis B virus infection as a risk factor for chronic kidney disease
(Taylor & Francis, 2019-08)
Introduction: Hepatitis B virus is an important cause of liver disease and has numerous extra-hepatic manifestations. HBV leads to important morbidity and mortality in the general population and recent evidence suggests a ...
Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease
(KARGERBASEL, 2012)
Background: Matrix metalloproteinases (MMPs) play important roles in the pathophysiology of renal diseases, and imbalanced MMP-2 and its endogenous inhibitor (the tissue inhibitor of metalloproteinases-2; TIMP-2) are ...